Patents by Inventor Jonathan Edward Shelton

Jonathan Edward Shelton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of 5-HT7 receptor antagonist and serotonin reuptake inhibitor therapy
    Patent number: 8883808
    Abstract: Patients suffering from serotonin-mediated diseases or conditions, such as depression, may be treated by administering an effective combined amount of a 5-HT7 receptor antagonist and a serotonin reuptake inhibitor.
    Type: Grant
    Filed: October 18, 2006
    Date of Patent: November 11, 2014
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Pascal Bonaventure, Christine Dugovic, Curt A. Dvorak, Dale A. Rudolph, Jonathan Edward Shelton
  • Chimeric peptide antagonist for GPCR135 or GPCR142
    Patent number: 8299028
    Abstract: The chimeric polypeptide R3(B?23-27)R/I5 is described, which is a high-affinity antagonist for GPCR1 35 and GPCR1 42 over LGR7.
    Type: Grant
    Filed: January 23, 2008
    Date of Patent: October 30, 2012
    Assignee: Janssen Pharmaceutica NV
    Inventors: Chester Kuei, Changlu Liu, Cindy M. Pudiak, Jonathan Edward Shelton, Steven W. Sutton